Vir Biotechnology, Inc. (VIR)
9.10
-0.28
(-2.99%)
USD |
NASDAQ |
Mar 20, 16:00
9.08
-0.02
(-0.22%)
After-Hours: 20:00
Vir Biotechnology Research and Development Expense (Quarterly) : 85.53M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Hims & Hers Health, Inc. | 40.96M |
| BioMarin Pharmaceutical, Inc. | 192.41M |
| Xeris Biopharma Holdings, Inc. | 7.874M |
| Gossamer Bio, Inc. | 48.93M |
| Sensei Biotherapeutics, Inc. | 2.533M |